Abstract
The American Heart Association (AHA) radically changed the recommendations regarding endocarditis prophylaxis, if patients undergo dental work. For the vast majority of patients previously considered to be at significant risk for bacterial endocarditis (especially patients with degenerative and rheumatic heart disease), routine endocarditis prophylaxis is not longer recommended from a cost-benefit-risk standpoint. Only patient populations with a very high lifetime risk for bacterial endocarditis or an expected worse outcome (patients with prosthetic heart valves, conservatively treated endocarditis, and certain groups with congenital heart disease) are judged candidates for endocarditis prophylaxis. In 2007, a German position paper (S2 guideline) comments the AHA recommendations. This position paper allows a more individual approach, if treating physician and patient agree upon the benefit of endocarditis prophylaxis in the individual case.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
